The future of self regulation in the pharmaceutical sector has been thrown into doubt after one of the largest companies operating in the UK withdrew from an industry trade body.

The British arm of Roche of Switzerland resolved this spring not to renew its membership of the Association of the British Pharmaceutical Industry, after it was suspended for six months for “bringing the industry into disrepute”.